47 related articles for article (PubMed ID: 18309490)
21. Regulation of iron metabolism in the acute-phase response: interferon gamma and tumour necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients.
Feelders RA; Vreugdenhil G; Eggermont AM; Kuiper-Kramer PA; van Eijk HG; Swaak AJ
Eur J Clin Invest; 1998 Jul; 28(7):520-7. PubMed ID: 9726030
[TBL] [Abstract][Full Text] [Related]
22. Preclinical models of arthritic disease in non-human primates.
Vierboom MP; Jonker M; Tak PP; 't Hart BA
Drug Discov Today; 2007 Apr; 12(7-8):327-35. PubMed ID: 17395093
[TBL] [Abstract][Full Text] [Related]
23. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial.
Nishimoto N; Yoshizaki K; Miyasaka N; Yamamoto K; Kawai S; Takeuchi T; Hashimoto J; Azuma J; Kishimoto T
Arthritis Rheum; 2004 Jun; 50(6):1761-9. PubMed ID: 15188351
[TBL] [Abstract][Full Text] [Related]
24. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.
Nemeth E; Rivera S; Gabayan V; Keller C; Taudorf S; Pedersen BK; Ganz T
J Clin Invest; 2004 May; 113(9):1271-6. PubMed ID: 15124018
[TBL] [Abstract][Full Text] [Related]
25. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin.
Nicolas G; Bennoun M; Porteu A; Mativet S; Beaumont C; Grandchamp B; Sirito M; Sawadogo M; Kahn A; Vaulont S
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4596-601. PubMed ID: 11930010
[TBL] [Abstract][Full Text] [Related]
26. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice.
Nicolas G; Bennoun M; Devaux I; Beaumont C; Grandchamp B; Kahn A; Vaulont S
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8780-5. PubMed ID: 11447267
[TBL] [Abstract][Full Text] [Related]
27. Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys.
Mihara M; Kotoh M; Nishimoto N; Oda Y; Kumagai E; Takagi N; Tsunemi K; Ohsugi Y; Kishimoto T; Yoshizaki K; Takeda Y
Clin Immunol; 2001 Mar; 98(3):319-26. PubMed ID: 11237555
[TBL] [Abstract][Full Text] [Related]
28. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.
Maini R; St Clair EW; Breedveld F; Furst D; Kalden J; Weisman M; Smolen J; Emery P; Harriman G; Feldmann M; Lipsky P
Lancet; 1999 Dec; 354(9194):1932-9. PubMed ID: 10622295
[TBL] [Abstract][Full Text] [Related]
29. Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis.
Voulgari PV; Kolios G; Papadopoulos GK; Katsaraki A; Seferiadis K; Drosos AA
Clin Immunol; 1999 Aug; 92(2):153-60. PubMed ID: 10444359
[TBL] [Abstract][Full Text] [Related]
30. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
Charles P; Elliott MJ; Davis D; Potter A; Kalden JR; Antoni C; Breedveld FC; Smolen JS; Eberl G; deWoody K; Feldmann M; Maini RN
J Immunol; 1999 Aug; 163(3):1521-8. PubMed ID: 10415055
[TBL] [Abstract][Full Text] [Related]
31. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis.
Takagi N; Mihara M; Moriya Y; Nishimoto N; Yoshizaki K; Kishimoto T; Takeda Y; Ohsugi Y
Arthritis Rheum; 1998 Dec; 41(12):2117-21. PubMed ID: 9870868
[TBL] [Abstract][Full Text] [Related]
32. Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
Davis D; Charles PJ; Potter A; Feldmann M; Maini RN; Elliott MJ
Br J Rheumatol; 1997 Sep; 36(9):950-6. PubMed ID: 9376990
[TBL] [Abstract][Full Text] [Related]
33. Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease.
Jongen-Lavrencic M; Peeters HR; Wognum A; Vreugdenhil G; Breedveld FC; Swaak AJ
J Rheumatol; 1997 Aug; 24(8):1504-9. PubMed ID: 9263142
[TBL] [Abstract][Full Text] [Related]
34. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset.
Peeters HR; Jongen-Lavrencic M; Raja AN; Ramdin HS; Vreugdenhil G; Breedveld FC; Swaak AJ
Ann Rheum Dis; 1996 Mar; 55(3):162-8. PubMed ID: 8712878
[TBL] [Abstract][Full Text] [Related]
35. IL-6-induced anaemia in rats: possible pathogenetic implications for anemia observed in chronic inflammations.
Jongen-Lavrencic M; Peeters HR; Rozemuller H; Rombouts WJ; Martens AC; Vreugdenhil G; Pillay M; Cox PH; Bijser M; Brutel G; Breedveld FC; Swaak AJ
Clin Exp Immunol; 1996 Feb; 103(2):328-34. PubMed ID: 8565320
[TBL] [Abstract][Full Text] [Related]
36. Analysis of elevated serum interleukin-6 levels in rheumatoid arthritis: correlation with erythrocyte sedimentation rate or C-reactive protein.
Cohick CB; Furst DE; Quagliata S; Corcoran KA; Steere KJ; Yager JG; Lindsley HB
J Lab Clin Med; 1994 May; 123(5):721-7. PubMed ID: 8195678
[TBL] [Abstract][Full Text] [Related]
37. The anaemia of chronic disorders. A bag of unsolved questions.
Hansen NE
Scand J Haematol; 1983 Nov; 31(5):397-402. PubMed ID: 6648353
[No Abstract] [Full Text] [Related]
38. The anemia of chronic disease.
Lee GR
Semin Hematol; 1983 Apr; 20(2):61-80. PubMed ID: 6348957
[TBL] [Abstract][Full Text] [Related]
39. Blunted erythropoietin response to anaemia in rheumatoid arthritis.
Baer AN; Dessypris EN; Goldwasser E; Krantz SB
Br J Haematol; 1987 Aug; 66(4):559-64. PubMed ID: 3663512
[TBL] [Abstract][Full Text] [Related]
40. Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia.
Hochberg MC; Arnold CM; Hogans BB; Spivak JL
Arthritis Rheum; 1988 Oct; 31(10):1318-21. PubMed ID: 3178910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
